1. Home
  2. RDW vs DNTH Comparison

RDW vs DNTH Comparison

Compare RDW & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$6.62

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$41.42

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
DNTH
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RDW
DNTH
Price
$6.62
$41.42
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$12.67
$68.00
AVG Volume (30 Days)
7.5M
756.3K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,147,000.00
$3,078,000.00
Revenue This Year
$11.89
N/A
Revenue Next Year
$43.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$13.37
52 Week High
$26.66
$45.46

Technical Indicators

Market Signals
Indicator
RDW
DNTH
Relative Strength Index (RSI) 50.32 51.07
Support Level $5.11 $40.98
Resistance Level $8.20 $44.06
Average True Range (ATR) 0.58 1.74
MACD 0.21 -0.52
Stochastic Oscillator 48.06 24.17

Price Performance

Historical Comparison
RDW
DNTH

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: